We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$6.19B
AUM Growth
+$180M
Cap. Flow
-$115M
Cap. Flow %
-1.85%
Top 10 Hldgs %
21.67%
Holding
241
New
11
Increased
68
Reduced
137
Closed
2

Top Buys

Rank Stock Value
1
RXO icon
RXO
RXO
+$16.9M
2
CLF icon
Cleveland-Cliffs
CLF
+$11.1M
3
CVS icon
CVS Health
CVS
+$8.97M
4
AA icon
Alcoa
AA
+$8.4M
5
IFF icon
International Flavors & Fragrances
IFF
+$7.96M

Sector Composition

Rank Sector Weight
1 Financials 17.68%
2 Technology 16.56%
3 Healthcare 15.52%
4 Industrials 11.68%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
26
Bank of America
BAC
$441B
$79.6M 1.29%
2,776,148
+39,632
+1% +$1.13M
GSK icon
27
GSK
GSK
$104B
$79.3M 1.28%
2,224,102
+61,812
+3% +$2.22M
GDDY icon
28
GoDaddy
GDDY
$11.4B
$76.8M 1.24%
1,022,293
-32,732
-3% -$2.42M
LOW icon
29
Lowe's Companies
LOW
$122B
$76.3M 1.23%
337,929
-20,045
-6% -$4.17M
IR icon
30
Ingersoll Rand
IR
$34.2B
$74.2M 1.2%
1,135,283
-11,546
-1% -$683K
JNJ icon
31
Johnson & Johnson
JNJ
$619B
$74M 1.19%
446,793
+34,122
+8% +$5.51M
BUD icon
32
AB InBev
BUD
$165B
$71.2M 1.15%
1,254,966
+34,185
+3% +$2.07M
STZ icon
33
Constellation Brands
STZ
$22.6B
$70.7M 1.14%
287,367
-11,912
-4% -$2.79M
KO icon
34
Coca-Cola
KO
$374B
$70.3M 1.14%
1,167,388
-27,305
-2% -$1.7M
CVX icon
35
Chevron
CVX
$371B
$69.7M 1.13%
442,803
-6,061
-1% -$972K
IFF icon
36
International Flavors & Fragrances
IFF
$21.6B
$68.8M 1.11%
864,353
+92,476
+12% +$7.96M
SHEL icon
37
Shell
SHEL
$248B
$68.2M 1.1%
1,130,246
-42,370
-4% -$2.54M
META icon
38
Meta Platforms (Facebook)
META
$1.5T
$64.3M 1.04%
223,953
-22,480
-9% -$5.55M
CVS icon
39
CVS Health
CVS
$123B
$63.3M 1.02%
915,763
+126,108
+16% +$8.97M
AMT icon
40
American Tower
AMT
$79.8B
$63M 1.02%
324,948
+9,073
+3% +$1.77M
EOG icon
41
EOG Resources
EOG
$71.4B
$62.5M 1.01%
545,784
-847
-0.2% -$96.7K
HON icon
42
Honeywell
HON
$76.3B
$62.4M 1.01%
318,996
-4,813
-1% -$894K
AES icon
43
AES
AES
$10.5B
$60.5M 0.98%
2,917,382
+77,715
+3% +$1.71M
MRK icon
44
Merck
MRK
$317B
$58.6M 0.95%
508,143
-15,405
-3% -$1.75M
HLN icon
45
Haleon
HLN
$44.2B
$58.6M 0.95%
6,996,652
+332,883
+5% +$2.84M
ILMN icon
46
Illumina
ILMN
$29.3B
$55.7M 0.9%
305,657
-6,058
-2% -$1.23M
USB icon
47
US Bancorp
USB
$99.4B
$53.9M 0.87%
1,630,809
+7,359
+0.5% +$238K
DIS icon
48
Walt Disney
DIS
$182B
$53M 0.86%
593,270
+4,220
+0.7% +$400K
UBER icon
49
Uber
UBER
$143B
$52.1M 0.84%
1,205,969
-30,317
-2% -$1.13M
XPO icon
50
XPO
XPO
$23B
$49.9M 0.81%
846,447
-31,396
-4% -$1.42M

Similar funds

Douglas Lane & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Douglas Lane & Associates held 241 positions worth $6.19B, up 3% from $6.01B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas Lane & Associates's Q2 2023 filing shows 11 new, 68 increased, 137 reduced and 2 closed positions. Its largest new stake was Wheaton Precious Metals: 108,375 shares worth $4.68M. The largest sale was Maxar Technologies Inc. Common Stock, an estimated $82.8M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Douglas Lane & Associates's largest Q2 2023 buy was Wheaton Precious Metals: 108,375 shares worth $4.68M.
  • Douglas Lane & Associates added most to RXO in Q2 2023, an estimated $16.9M increase.
  • Douglas Lane & Associates's biggest Q2 2023 reduction was Electronic Arts, cutting an estimated $23.5M.
  • Douglas Lane & Associates fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $82.8M.
  • Douglas Lane & Associates's ten largest holdings make up 22% of its $6.19B portfolio in Q2 2023.
  • Douglas Lane & Associates opened 11 new positions and closed 2 in Q2 2023.
  • Douglas Lane & Associates's portfolio value rose 3% quarter-over-quarter to $6.19B.

Based on Douglas Lane & Associates's 13F filing for Q2 2023, filed 19 Jul 2023.